Ampio Pharmaceuticals receives approval to trade under new stock trading symbol "AMPE"

Ampio Pharmaceuticals, Inc. (OTC Bulletin Board: AMPE, www.ampiopharma.com), announced it has received approval for a new stock trading symbol from FINRA Operations. Effective March 31, 2010, Ampio Pharmaceuticals, Inc. will trade under the symbol "AMPE," and Ampio's common stock will carry a new CUSIP number,  03209T  109. The symbol change follows the March 24 change in the company's corporate name from Chay Enterprises, Inc. to Ampio Pharmaceuticals, Inc., and its reincorporation in Delaware.  

The reincorporation will not result in any changes in the assets, operations or management of the company. The company's common stock will continue trading, uninterrupted, on the over-the-counter bulletin board. Stock certificates currently held by the company's stockholders represent ownership of the same number of shares of the Delaware corporation (and the same percentage ownership of the company) as they had represented in the Colorado corporation prior to the reincorporation. Stockholders do not need to exchange their stock certificates for new stock certificates, but they may elect to do so. Stockholders interested in exchanging their stock certificates should contact the company's transfer agent at Corporate Stock Transfer, Inc., 3200 Cherry Creek Drive South, Suite 430, Denver, Colorado 80209, Attention: Shari Humphreys, or at [email protected].

"In less than one year, Ampio has gone from acquiring our intellectual property centered around new uses for previously approved drugs, to rounding out our management team, to becoming a public company, and to implementing our name change and change in corporate domicile," said Don Wingerter, CEO of Ampio. "As we look forward to implementing the next steps in our strategic growth plan, we felt it was an appropriate time to reincorporate in Delaware with its highly predictable corporate environment."

SOURCE Ampio Pharmaceuticals, Inc.